An apparently unprecedented restriction of future FDA spending is slated to be included in user fee reauthorization legislation.
Beginning Oct. 1, 2023, the agency will not be able to use user fee money for building maintenance and other...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?